Odyssey Health (ODYY) Other Non-Current Assets (2017 - 2022)

Odyssey Health (ODYY) reported Other Non-Current Assets of $366475.0 for Q3 2022, up 747.34% sequentially from $43250.0 in Q2 2017.

Odyssey Health (ODYY) Other Non-Current Assets (2017 - 2022) Analysis & Trends

Odyssey Health has disclosed Other Non-Current Assets across 2 years of filings, most recently posting $366475.0 for Q3 2022.

Quarterly Other Non-Current Assets changed N/A year-over-year to $366475.0 in Q3 2022, while the trailing twelve-month figure through Jul 2022 was $366475.0 (changed N/A YoY) and the FY2022 annual result came in at $366475.0, changed N/A from the prior year.
Other Non-Current Assets rose to $366475.0 in Q3 2022, from $43250.0 in the prior quarter.
Across five years, Other Non-Current Assets topped out at $366475.0 in Q3 2022 and bottomed at $366475.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	3.17 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	4.04 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	44.35 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	738.90 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	828.89 Mn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	285.90 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	2.25 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	211.40 Mn
10	Odyssey Health	-	-	-	-

Download Data